Donation will lead to a reduction in turnaround time for test results, including of Delta and Mu variants
TRINIDAD and TOBAGO (September 14, 2021) This week, AIDS Healthcare Foundation (AHF), the largest global AIDS organization, signed an agreement with The University of the West Indies (UWI), St. Augustine Campus, Trinidad and Tobago to provide a gene sequencing analyzer and reagents to expand the capacity of the university to test for new and emerging variants of the coronavirus. This will improve the region’s sequencing capacity and contribute to reducing testing turnaround times.
Jamaica and many of the countries in the Region are now experiencing severe upsurges of Covid-19 caused by the Delta variant, with many hospitals exceeding capacity and others running out of oxygen. More recently five cases of the Mu variant were also identified in St. Vincent.
Dr. Kevin Harvey, the Caribbean Regional Director at AHF, in welcoming the agreement, noted that the machine is already on order and should be in place within the next two to three weeks. “The Mu variant has since been isolated in samples from Jamaica as well, making the timeliness of AHF’s donation of the gene sequencing analyzer and reagents all the more critical,” noted Dr. Harvey.
“Our COVID-19 IMPACT project, a UWI-led collaboration with CARPHA (the Caribbean Public Health Agency) and the Trinidad and Tobago Ministry of Health, established local capacity for virus whole genome sequencing in December 2020, and our laboratory at UWI has been carrying out genomic surveillance for SARS-CoV-2 variants for Trinidad and Tobago and 16 other CARPHA member states,” said Dr. Christine Carrington, Professor of Molecular Genetics and Virology at the UWI. “The current need and demand for genomic surveillance in the region has increased significantly, so we are extremely grateful for the AHF’s support. The device they are providing is faster and can also do five times as many samples as the device we started off with, so it will help to increase our throughput.”
Dr. Jorge Saavedra the executive Director of the AHF Global Public Health Institute at the University of Miami, highlighted the project as part of a larger initiative by AHF to improve the early detection of new variants to enable proper planning, and in some cases, expansion of existing genomic sequencing initiatives and implementation of mitigation measures in several of the countries served by AHF that can inform public policy. “AHF is also now in final negotiations to provide support to establishing genomic sequencing capacity in Jamaica to reduce the need for all samples to be sent to Trinidad and Tobago.”
AHF has also previously provided similar support to Brazil, Uganda, Mexico, India, Argentina, and before the end of the year, will undertake other similar initiatives in Nigeria, Peru, Ukraine and Pakistan.